Spice. Synthetic cannabinoids (SCRAs). by unknown
Spice is a nickname for a herbal mixture containing 
one or more of a group of drugs called synthetic 
cannabinoids. 
Spice was originally a brand name of a drug, sold 
as a ‘legal high’ along with other brand names like 
Black Mamba, Annihilation, Exodus Damnation and 
Happy Joker. They contained a non-psychoactive 
herbal smoking mixture that had been mixed with 
one or more of a group of drugs known as Synthetic 
Cannabinoid Receptor Agonists (to give them their full 
name) or SCRAs for short.
Spice (and Mamba) are now used as nicknames for any 
type of herbal mixture that has been coated with an 
SCRA. SCRAs can also appear as powders or liquids 
for use in e-cigarettes although in the UK SCRAs are 
now almost always smoked in a herbal form, however, 
SCRAs have also turned up as adulterants in a number 
of other drugs. In recent incidents in Oldham, pure 
crystals of SCRAs were sold as MDMA resulting in 
multiple hospital admissions.1
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Spice was sold in branded packets but is now mainly 
sold in clear snap bags.
What is Spice?
What are SCRAs? The cannabis plant contains a number of natural cannabinoids. THC (tetrahydrocannabinol) is the main 
one that gets you high.5 CBD (cannabidiol) and CBN 
(cannabinol) have more relaxing and calming effects 
and moderate the effects of THC.6,7,8 
Cannabinoids stimulate receptor sites called CB1 and 
CB2 (found in the brain and all over the body).6,7,8 
Stimulating these receptor sites leads to a wide range 
of effects on mood, thoughts, feelings and senses as 
well as a number of physical effects. SCRAs may bear 
no structural similarity to natural cannabinoids but, 
like THC, they also stimulate CB1 and CB2 receptors.6,7,8 
SCRAs may also have activity on the serotonin and 
dopamine systems.
SCRAs were designed by commercial research chemists 
in the 1980s, although they were never manufactured or 
clinically tested on humans. 
SCRAs may have started out as legal cannabis 
substitutes, but the market changed and users wanted 
Spice products that were increasingly potent. Spice 
became an extremely potent product and quite unlike 
cannabis.
Cannabis only partially stimulates CB1 and CB2 
receptors, whereas SCRAs can fully stimulate them. 
SCRAs have been described as ‘Super stimulators’ and 
can be up to 800 times more potent than cannabis.9 
SCRAs also may lack the calming effect of CBD/CBN 
found in cannabis.9
SCRAs are made in a lab and stimulate the same 
areas of the brain as THC.
Why is Spice so potent?
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A pinch of Spice the size of a match-head 
is an active dose.
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There are hundreds of different SCRAs, some much 
stronger and more toxic than others. The potency of 
a packet of Spice depends on which SCRAs are used 
and how much is added to the herbal mixture. Spice 
is potent even at very low doses: a pinch the size of a 
match-head is an active dose.10 
Since changes to the law in 2016,2,3 Spice mixtures 
are now almost always sold in clear snap bags. On the 
street in Manchester Spice sells for approximately £5 
for 1⁄2 and £10 for 1 gram bags.4 Prices in prison are 
much higher.5
SCRAs are mainly still made in China and imported as 
a powder into the UK, although there are unconfirmed 
reports of it being imported as a liquid via eastern Europe. 
SCRAs are then mixed (in a bath, cement mixer etc.) with 
a herbal smoking mixture in the UK and packaged into 
snap bags.  
Current Spice content
Who is using Spice?
Is Spice legal?
The original product sold under the brand name ‘Spice’ 
contained an SCRA called JWH-018. A range of SCRAs 
such as JWH-018 were made Class B under the Misuse of 
Drugs Act in 2009.
However, these were replaced in the shops within days 
by branded products containing a second generation of 
SCRAs that were not covered by the Misuse of Drugs Act 
such as AM-2201 (the drug in the original Black Mamba 
brand). These SCRAs were often more toxic and more 
potent than the ones they replaced. 
The Misuse of Drugs Act was amended in 2013 so that 
AM-2201 and a range of other SCRAs were included. 
Hundreds of SCRAs were banned but within days these 
were again replaced with others not covered by the 
Misuse of Drugs Act.
All SCRAs became illegal to sell, make, import and 
export in April 2016 under the Psychoactive Substances 
Act,1 but were only illegal to possess in prison.
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5F-ADB
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Since the advent of the Psychoactive Substances Act, 
little has been known about the SCRAs that are used 
in the Spice products sold in plain snap bags.4 In March 
and April 2017 a number of Spice products were tested 
in Manchester11 and the content varied in both the SCRA 
used and the ratio of plant material to SCRA. In other 
words the potency and toxicity can vary between 
packets and may change from week to week.
The SCRAs found in the test in March and April were 
all highly potent: AMB-FUBINACA, AMB-CHMICA, 
5F-AMB and 5F-ADB. 12,13,14,15 To make things even more 
confusing SCRAs are named in different ways. So for 
instance 5F-ADB has a chemical long name of N-[[1-(5-
fluoropentyl)-1H-indazol-3-yl]carbonyl]-3-methyl-D-
valine methyl ester. It is known as 5F-ADB for short but 
is also known as 5F-MDMB-PINACA.16
The Misuse of Drugs Act was amended again in 
December 2016,3 so now most* of the known SCRAs and 
all those commonly found in Spice have become Class B 
drugs and are illegal to possess etc. 
SCRAs are now mostly* Class B drugs.
* There are a number of SCRAs that although not currently in 
common use, are not controlled by the latest amendment to the 
Misuse of Drugs Act. These are MDMB-CHMCZCA, EG-018 (only 
seen as powder) and CUMYL-PeGACLONE.
Drug screens & detection
Although Spice does have a smell when smoked, it is far 
less noticeable than cannabis and often is undetectable 
by smell alone when mixed with tobacco.
As stated Spice was originally sold as a ‘legal high’ 
designed to mimic the effects of cannabis and was used 
by a wide range of people, although nearly all of them 
had used illegal drugs before using Spice.5 
As the product became more potent and developed 
a negative reputation it started to be associated with 
specific groups of people: prisoners, rough sleepers, 
psychiatric in-patients and young people often described 
as ‘vulnerable’.5 Drugs are not used in a vacuum and it 
is important to understand the particular issues these 
groups face when working with Spice users.9
SCRAs cannot be detected by screening tests for 
THC. There are a number of specific drug screens for 
particular SCRAs but many new ones may not appear in 
simpler tests.9 
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“Whatever approaches are used, interventions should 
also address issues specific to SCRAs and to particular 
populations who appear to be using them. Underlying 
drivers of use can include misuse of other substances, 
mental health and physical health comorbidity,
issues associated with homelessness and deprivation, 
and involvement in the criminal justice system and 
incarceration.” 9 
“What we found was not that people were using Spice
because they were bored but mainly as a coping 
mechanism and to self-medicate because the reasons why 
they are in prison in the first place have gone untreated.”17
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Duration of Effects
The full effects are felt within seconds if smoked, before 
tailing off after 30 minutes to a more manageable state. 
Effects usually last 1-2 hours but can last much longer 
with some SCRAs. Spice is often smoked continuously 
throughout every waking hour (while supplies last).
Common physical effects
Tight chest, racing & irregular pulse, breathing 
difficulties, collapse, dizziness, numbness and vomiting 
are commonly reported physical effects of Spice.9
Physical problems
Seizures, cardiac toxicity, sympathomimetic toxidrome 
(poisoning), chest pain, heart attack, renal injury, 
hypertension, hypokalemia (low potassium levels), skin 
rash have been reported,9 while other effects such as 
bleeding from the eyes and other orifices, teeth falling 
out are described by some long term users but have yet 
to be recognised in the literature. 5
Emergency hospital admissions
There are no national figures for emergency admissions 
for Spice-related incidents, but could be estimated 
in the thousands per year. In one day in April 2017 in 
Manchester there were 58 ambulance call-outs reported 
that were related to Spice in the city centre, although 
some of these may have been related to the same 
incident. 18
Death
Although ambulance call-outs and A&E admissions are 
common, deaths are relatively rare. 8 deaths associated 
with Spice were reported in England and Wales in 2015.19 
The physical effects of Spice
For new users, the mental effect of large doses or 
potent Spice the mental effects can be overpowering. 
Effects are unlike cannabis and often described as, more 
akin to the effects of ketamine or solvents. 
Spice can cause frightening visions or hallucinations. It 
can take you to what feels like a different reality, almost 
the same as this one, but a lot more scary. The mental 
effects together with the physical effects can cause 
panic. 
“. . . the user will experience a true test of fate. Reality, 
perception, and consciousness will become severely 
altered to the point of one not knowing their own name, 
address, or that they are even a human being”.20
The mental effects of Spice
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Tolerance develops in a matter of days of regular use. 
The effects seem more exaggerated over time so a 
state often described as ‘zombie-like’ is commonly and 
constantly experienced by heavy Spice users. However, 
large doses or (as there does not appear to be cross 
tolerance) a different SCRA can bring on the more 
extreme state described even among experienced 
regular users.9
There are a wide range of mental effects described:
anxiety, irritability and psychosis-like effects, 
inappropriate or uncontrolled laughter, anger, sadness, 
flat effect, depression and suicidal thoughts, excitability, 
agitation, combativeness, aggression, thought 
disorganisation, panic attacks, paranoid thinking, 
delusions, auditory and visual hallucinations, changes in 
perception, acute psychosis.9 
Short-term memory and cognitive deficits, confusion, 
sedation and somnolence, thought blocking, nonsensical 
speech, amnesia and increased focus on internal unrest 
are also reported.9 
Psychotic symptoms
“Psychotic symptoms appear to occur relatively frequently 
following SCRA consumption. More research is needed, 
but this may be linked to the high potency of the drugs 
and the fact that, unlike natural cannabis, SCRAs do not 
contain cannabidiol (CBD), a chemical which appears to 
possess antipsychotic properties.”9
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Dealing with Spice overdose
The number of Spice overdoses has placed a strain on 
already over-stretched emergency services. There are 
a number of simple guides to advise with when to dial 
999.21,22,23 However, these guides still require staff capable 
of taking blood pressure and accurately monitoring pulse 
rate and temperature.
The following visual guide is based on the DrugWatch 
Information Sheet,24, Euro-DEN21 and information from 
Project NEPTUNE.9 It is aimed primarily at non medical 
professionals. In all drugs cases it is advisable to treat 
the symptoms and not the drug, as more than one drug 
may have been used and people may not have taken the 
drug(s) they think they have.
Breathing difficulties, such as fast 
breathing rate, not settling within 
5 minutes. If there is no breathing 
or it is abnormal (e.g. death rattle, 
agonal breath) then CPR should be 
attempted. 
Call an ambulance.
Unconsciousness: it can be 
risky to startle or frighten people 
intoxicated on Spice as this can 
lead to heart failure. If they can’t 
be woken by gentle shaking and 
calling, or you notice a blueness of 
the skin, including lips or fingernails 
(or greyish with paler lips for 
darker complexions), make sure 
they are lying on their side so they 
don’t choke on vomit and call an 
ambulance. 
 
Other concerns: e.g. severe 
vomiting, frothing at mouth, severe 
headache, significant agitation or 
aggression, not settling within 15 
minutes. Call an ambulance.  
Spice Intoxication: people who 
have used Spice may act in a 
disturbing way, be unsteady and 
appear ‘zombie-like’ with pale skin 
and pink eyes. They will be confused, 
unable to communicate properly 
and may repeat actions, as short 
term memory is severely affected. 
However in the vast majority of cases 
people will not require emergency 
treatment.9
If in doubt call an ambulance.
Hallucinations, blabbering, 
incoherent, zombie-like behaviour, 
panic attacks, repetitive nonsensical 
actions are common when using 
Spice. Take them somewhere quiet 
where they feel safe (a low stimulus 
environment). Make eye contact, 
build trust. Calm and reassure them. 
If they become panicky and you 
notice them breathing very fast, get 
them to control their breathing by 
slowing it down or breathing into a 
paper bag.  
Vomiting/feeling unwell: 
vomiting is nature’s way of saying 
you’ve had too much. If somebody 
is unwell, don’t give them anything 
to eat and only let them drink water. 
If after vomiting they want to sleep, 
let them but keep your eye on them. 
Make sure they are lying on their side 
(the recovery position) 
Temperature over 38.5°C, not 
settling after about 5 minutes of rest 
or, if no thermometer is available, if 
very flushed and feels very hot. Call 
an ambulance. 
If they are overheating: cool 
them down by removing outer 
clothing, fan them, use a wet cloth 
on their skin, take them outside 
or somewhere cool. If they are 
conscious allow them to sip water or 
a non alcoholic drink. 
Serotonin syndrome: some SCRA 
compounds may increase the risk of 
serotonin syndrome.9
The main symptoms: rigid, jerky, 
twitchy unusual movements, often 
involving the legs shaking, fully dilated 
pupils, overheating, shivering, racing 
heart, agitation and confusion.
Severe chest pains: sit them down 
in a calm environment and reassure 
them. Call an ambulance. 
Heart rate over 140 beats per 
minute, not settling within 5 minutes. 
Call an ambulance. 
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Seizures (convulsion similar to an 
epileptic fit). Make sure the area 
is safe and there is nothing they 
could hurt themselves on. Call an 
ambulance. Inform paramedics if the 
fit stops and starts, if it doesn’t stop 
within a couple of minutes or if the 
person turns blue. It is important 
not to hold people down because 
of the risk of rhabdomyolysis. 
If in any doubt call 999
Dependence
Psychological dependence can occur with any 
substance, but physical dependence and a recognised 
withdrawal from SCRAs are beginning to be recognised 
in literature. 9 Services commonly report that the most 
noticeable effect of SCRA dependence is a change 
in behaviour, with people becoming withdrawn and 
aggressive often resorting to crime to pay for SCRAs.5 
Tolerance 
Tolerance to SCRAs is rapid; it has been reported 
that within a week of commencing use that 6 grams 
a day or more is used.5 It is often stated that Spice is 
used in every waking moment and often waking from 
disturbed sleep to smoke in the middle of the night.5 
It is commonly stated that within days of first use the 
initial extreme effects (falling over, altered reality) 
are moderated into a state described as somewhere 
between heavy cannabis intoxication and a heroin 
‘gouch’.5 However, it is also reported that there is no 
Interacting medicine
(list not exhaustive)
Potential effect
Antifungals: itraconazole,
ketoconazole, fluconazole
Macrolide antibiotics: 
clarithromycin, 
telithromycin, erythromycin
Anti-HIV drugs: indinavir, 
nelfinavir, ritonavir, 
saquinavir
Antipsychotics: clozapine,
quetiapine
These medicines 
inhibit the liver 
enzyme CYP3A4.
This leads to an 
increase in plasma
level of SCRA and
decreased rate of 
clearance which 
potentiates its 
toxicity.
Concomitant use may 
cause brain, kidney, 
liver or heart injury.
Little is known about the risks of using SCRAs with 
other drugs, alcohol or medicines, let alone specific risks 
with different SCRAs. Any drug combinations should be 
considered potentially dangerous. Some SCRAs may be 
associated with activation of serotonin receptors. Due to 
the lack of clear information, decisions about continuity 
of prescribed medicines should be made on a case-by-
case basis.25
It is advised that essential medication, such as insulin 
or warfarin is maintained but monitored. Given the 
association between SCRA use and convulsions, it is 
important to maintain prescribing of antiepileptic 
drugs. 25
SCRA interaction with medicines
5
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Tolerance, dependence & withdrawal
‘cross-tolerance’ between different SCRAs and when 
the specific SCRA in a batch of Spice changes, the full 
‘extreme’ effects are felt again.5
Withdrawal
Anecdotally, physical withdrawal is widely reported 
(and in fact is the norm) among people describing 
experiences of SCRA addiction. 5 The withdrawal profile 
is similar but more intrusive and intense than seen with 
‘skunk’ withdrawal. Diaphoresis (extreme sweating) 
and insomnia/sleep disturbance are the most common 
and noticeable withdrawal symptoms,5 with some 
often waking with bed sheets soaked. Stomach cramps 
are reported anecdotally and some describe mental 
disturbances that can continue for months after use has 
ceased.5 
Withdrawal symptoms including; headaches, anxiety, 
coughing, impatience, difficulty concentrating, anger/
irritability, restlessness, nausea, depression, craving, 
tremor and hypertension are recognised in the literature.9 
There is drug no substitute therapy known for Spice; 
drug treatment involves prescribing to alleviate 
withdrawal symptoms.9
Treatment for withdrawal
Short term benzodiazepines (such as diazepam) are 
used to assist sleep, manage anxiety, panic and agitation. 
Treatment with intravenous benzodiazepines has been 
reported for the management of seizures and in some 
cases of SCRA-related psychosis.9
There are some reports describing antipsychotic 
medication being indicated for some patients, especially 
those who present with agitation or aggression, when 
the patient has a history of psychotic disorders, and 
when the psychotic symptoms do not remit with 
supportive care. There are also a small number of reports 
that describe antidepressants being administered in 
cases where there is concurrent depression.9
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Psychosocial treatment
Very little evidence is available on the management of 
the harmful or dependent use of SCRAs; it is suggested 
that clinicians adopt the evidence-based approaches 
used for other drugs, particularly natural cannabis.
There is no evidence to suggest that a particular 
approach is linked to successful outcomes for SCRA 
users.9
The FRAMES model26 (feedback, responsibility, advice, 
menu of options, empathy, self-efficacy), initially 
developed as a brief intervention for risky or harmful 
alcohol consumption can be an effective means of 
engagement and retaining people in treatment. It can 
be used in a formal or intuitive way, and it is reported 
to be effective in the context of managing SCRA use in 
prisons.25
Anecdotally, users often try to withdraw by reducing 
SCRA use and self medicate by switching back to 
cannabis. However the effects of even potent ‘skunk’ 
often seem weak compared to SCRAs, so it may be 
several weeks after ceasing SCRA use before potent 
cannabis is an effective substitute.5 
Drug treatment
Chart based on information from PHE25
6Harm reduction
There is no safe way to use Spice 
It is not the same as cannabis. Spice is more potent, more 
unpredictable and more dangerous.
It is illegal to possess (most) Spice 
Most synthetic cannabinoids, the chemicals in Spice, are 
illegal to possess, are now are covered by the Misuse of 
Drugs Act as Class B drugs. 
Spice varies from batch to batch 
Different packets can produce different effects.
Sit down before you use
In case you fall over.
Start with a very small dose 
Use a match-head size (or less) test dose with every new 
packet. Potency is hugely variable.  
Wait before the effects have worn off before 
smoking more 
Spice should not be smoked neat 
Always smoke with a ‘mixer’ (e.g. tobacco or dried 
herbs).
Use thin cigarette papers
If smoking in a joint use thinnest papers and avoid using  
printed card for a roach to avoid inhaling additional 
fumes.
Avoid using Spice with other drugs
Avoid using with cannabis, alcohol or stimulants, this may 
raise the risk of heart problems.
Avoid mixing Spice with medicines and alcohol.  
Be cautious with pipes
Be cautious about dosing in pipes or vaporisers: it is 
harder to regulate intake and easy to take too much. If 
smoking in a pipe, use small glass or steel pipes which 
give off less fumes than wood or plastic pipes.
Be VERY cautious about using in bongs 
It is harder to regulate intake and easy to take too much. 
Water pipes also causes you to inhale more deeply which 
can cause more lung damage.
Don’t get competitive
There is a high risk of overdosing if you get into bouts of 
competitive use (e.g. in bucket bongs etc.).
Beware the bottom of the bag
Be careful with dosing the crystalline powder material 
in the bottom of the bag; use a smaller dose, as this 
is generally stronger than the plant material which is 
coated with the SCRA.
Careful with powder
If sourcing pure powder SCRAs only use very small 
doses, calculated using scales and thoroughly mixed into 
smoking material.
Spice is very addictive
Regular use of Spice can lead to dependence (addiction) 
and withdrawal.
Spice is dangerous
Spice can cause severe harms. If you experience a 
sustained period of fast heart rate or chest pains, call an 
ambulance. 
Spice can make you anxious
Spice may exacerbate anxiety and paranoia. Only use in 
an environment in which you feel safe, with people you 
trust.
Spice can make mental health problems worse
If you suffer from anxiety or mental health problems, 
avoid using Spice. 
Do not drive or operate machinery under the influence 
of Spice.
This harm reduction advice is based on10,24,27.
Help available for Spice users
There are various treatments for Spice users provided by local adult and young peoples drug services, including 
medically assisted withdrawal. The FRANK website lists local service contact details.
http://www.talktofrank.com/need-support 
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Spice is a highly addictive, highly toxic drug that can and has killed people. 
The following advice is designed to reduce some of the risks for those already using Spice, 
but there is no safe way to use Spice. Spice users should be advised to seek help.
Harm reduction advice for SCRA users should take into 
account underlying issues that groups such as prisoners 
or rough sleepers face.9
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